Player FM 앱으로 오프라인으로 전환하세요!
What we know, and do not know, about the Omicron variant | In Focus
Manage episode 308398238 series 2606066
There is much that is still unknown about Omicron, the newest Sars-CoV-2 variant, that has been designated as a 'variant of concern' by the World Health Organisation. The variant was first reported in South Africa on November 24, and has since, spread to over 15 countries or regions, as of now. In response, several countries have begun imposing travel restrictions and closing borders, similar to what we saw happening last year, during the initial waves of the pandemic.
Omicron is a heavily mutated strain, with over 32 mutations in the spike protein of the virus, some in part of the protein required for binding to human receptor proteins for entry into cells. This has raised concerns that the variant may be more transmissable and also that it may hamper the efficacy of our current treatments for the disease. Another concern has been that the variant may have vaccine escape properties. However, scientists will require possibly several more weeks before they can determine whether any of these concerns are valid.
What do we now know about the variant? Are travel restrictions and bans really effective, given that the new variant is already spreading? With India having vaccinated nearly 80% of the eligible population with the first dose and about 38% with both doses, what more needs to be done to take measures against the new variant?
Guest: Dr. Shahid Jameel, Virologist and Fellow at OCIS and Green Templeton College, University of Oxford
Host: Zubeda Hamid
826 에피소드
Manage episode 308398238 series 2606066
There is much that is still unknown about Omicron, the newest Sars-CoV-2 variant, that has been designated as a 'variant of concern' by the World Health Organisation. The variant was first reported in South Africa on November 24, and has since, spread to over 15 countries or regions, as of now. In response, several countries have begun imposing travel restrictions and closing borders, similar to what we saw happening last year, during the initial waves of the pandemic.
Omicron is a heavily mutated strain, with over 32 mutations in the spike protein of the virus, some in part of the protein required for binding to human receptor proteins for entry into cells. This has raised concerns that the variant may be more transmissable and also that it may hamper the efficacy of our current treatments for the disease. Another concern has been that the variant may have vaccine escape properties. However, scientists will require possibly several more weeks before they can determine whether any of these concerns are valid.
What do we now know about the variant? Are travel restrictions and bans really effective, given that the new variant is already spreading? With India having vaccinated nearly 80% of the eligible population with the first dose and about 38% with both doses, what more needs to be done to take measures against the new variant?
Guest: Dr. Shahid Jameel, Virologist and Fellow at OCIS and Green Templeton College, University of Oxford
Host: Zubeda Hamid
826 에피소드
모든 에피소드
×플레이어 FM에 오신것을 환영합니다!
플레이어 FM은 웹에서 고품질 팟캐스트를 검색하여 지금 바로 즐길 수 있도록 합니다. 최고의 팟캐스트 앱이며 Android, iPhone 및 웹에서도 작동합니다. 장치 간 구독 동기화를 위해 가입하세요.